Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

23.57
-1.0300-4.19%
Post-market: 23.570.00000.00%16:04 EST
Volume:410.13K
Turnover:9.72M
Market Cap:1.57B
PE:-6.97
High:24.78
Open:24.57
Low:23.09
Close:24.60
52wk High:30.50
52wk Low:14.40
Shares:66.45M
Float Shares:53.21M
Volume Ratio:0.63
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3819
EPS(LYR):-2.4515
ROE:-32.44%
ROA:-21.77%
PB:2.62
PE(LYR):-9.61

Loading ...

Dec 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Aug 20, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 06, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report